Latest Breaking News On - Subsequent new drug approval - Page 1 : comparemela.com

AstraZeneca Pharma India receives permission for Dapagliflozin tablets

AstraZeneca Pharma India Ltd has received an Import and Market permission in Form CT-20 from the CDSCO , Directorate General of Health Services, Government of India for Dapagliflozin i.e., Forxiga® tablets of 10 mg - additional indication.

Dapagliflozin forxigaHealth servicesAstrazeneca pharma indiaCentral drugs standard control organisationZeneca pharma india limitedSubsequent new drug approvalDirectorate generalAstrazeneca pharma india limited

Astrazeneca Pharma share rises 2% on DCGI nod for cancer drug

AstraZeneca Pharma share rises 2% on DCGI nod for cancer drug AstraZeneca Pharma share gained as much as 1.88 per cent to hit a high of Rs 3,480 after the drug maker received import and market permission from the DCGI for osimertinib tablets (Tagrisso) used in treatment of non-small cell lung cancer BusinessToday.In | March 12, 2021 | Updated 13:19 IST AstraZeneca Pharma share jumps 2% to Rs 3,480 Share of AstraZeneca Pharma gained nearly 2 per cent in opening deals on Bombay Stock Exchange on Friday after the drug maker received import and market permission from the Drugs Controller General of India (DCGI) for osimertinib tablets (Tagrisso) used in treatment of non-small cell lung cancer. Meanwhile, Sensex was trading 349 points or 0.68 per cent higher at 51,628.

Astrazeneca pharmaBombay stock exchange onOxford universitySerum institute of indiaWorld health organisationBombay stock exchangeDrugs controller generalSubsequent new drug approvalPharma indiaSerum instituteAstrazeneca pharma shareAstrazeneca pharma share priceShares of astrazeneca pharmaAstrazeneca pharma cancer drugகுண்டு ஸ்டாக் பரிமாற்றம் ஆன்ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்

AstraZeneca Pharma India Limited receives approval for supplying Osimertinib in India

AstraZeneca Pharma India Limited receives approval for supplying Osimertinib in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesAstrazeneca pharma indiaZeneca pharma india limitedTime zoneMarket permissionSubsequent new drug approvalDrugs controller generalஒன்றுபட்டது மாநிலங்களில்ஸெநெக பார்மா இந்தியா வரையறுக்கப்பட்டவைநேரம் ஸோந்சந்தை அனுமதிமருந்துகள் கட்டுப்படுத்தி ஜநரல்

AstraZeneca set to launch Osimertinib 40mg/80mg film coated tablets

AstraZeneca set to launch Osimertinib 40mg/80mg film coated tablets
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca pharma indiaMarket permissionSubsequent new drug approvalDrugs controller generalCapital marketசந்தை அனுமதிமருந்துகள் கட்டுப்படுத்தி ஜநரல்மூலதனம் சந்தை

AstraZeneca s Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease

The company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets 10 mg," AstraZeneca Pharma India said in a filing to BSE.

New delhiDrugs controller generalMarket permissionSubsequent new drug approvalZeneca pharma indiaDapagliflozin tabletsAstrazeneca pharma indiaDrugs controllerபுதியது டெல்ஹிமருந்துகள் கட்டுப்படுத்தி ஜநரல்சந்தை அனுமதிஸெநெக பார்மா இந்தியாமருந்துகள் கட்டுப்படுத்தி